GlassScriptPhysician profile
Evelyn Hahn
NPI 1043756117
$1,169.93
in general payments reported to CMS, 2019-2025
17 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951 · Education: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.96 |
| Education | $218.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $460.48 | 2025 | Datroway, Imfinzi, Calquence |
| Astellas Pharma US INC | $148.76 | 2025 | Vyloy |
| Pfizer INC. | $63.56 | 2025 | |
| Genzyme Corporation | $59.11 | 2025 | |
| Merck Sharp & Dohme LLC | $55.07 | 2025 | Keytruda, Welireg |
| Regeneron Healthcare Solutions, INC. | $52.44 | 2025 | Lynozyfic, Libtayo |
| Array Biopharma INC | $42.02 | 2025 | Braftovi, Tukysa, Mektovi |
| Daiichi Sankyo INC. | $39.19 | 2025 | Enhertu, Datroway |
| Adc Therapeutics America, INC. | $35.13 | 2025 | |
| Exelixis INC. | $33.01 | 2025 | Cabometyx |
| Jazz Pharmaceuticals INC. | $32.62 | 2025 | |
| Eisai INC. | $29.05 | 2025 | |
| Beone Medicines USA, INC. | $28.55 | 2025 | Tevimbra |
| Tersera Therapeutics LLC | $27.99 | 2025 | Zoladex |
| Incyte Corporation | $24.77 | 2025 | Jakafi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $19.17 | 2025 | |
| Deciphera Pharmaceuticals INC. | $19.01 | 2025 | Romvimza, Qinlock |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.